Sun News Desk : ICDDR,B, and the Larner College of Medicine at the University of Vermont (UVM), togather conducted the trial of dengue vaccine for the first time in the country.
Read more : Nine dengue patients die
ICDDR,B, and the Larner College of Medicine at the University of Vermont (UVM), are the first to study a promising tetravalent dengue vaccine in dengue-endemic Bangladesh, said a press release on Thursday.
Their work, evaluating the single-dose tetravalent dengue vaccine candidate TV005, showed safety and immune responsiveness in children and adults, it said adding the accompanying study was recently published in the journal The Lancet Infectious Diseases.
Read more : Eid-e-Miladunnabi observed
Rashidul Haque, Senior scientist of ICDDR'B, said "The development of an effective and tetravalent dengue vaccine is a very high priority for the large population of Bangladesh, which is now having increasingly severe dengue outbreaks."
He also said "We are proud to participate in the evaluation of the TV005 vaccine in the Bangladeshi population and hope that our work will accelerate the development of dengue vaccines for our country."
Sun News/MR
Copyright © Sunnews24x7Newsletter
Subscribe to our newsletter and stay updated.
